Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer

Prostate

Volumn 73, Issue 3, 2013, Pages 236-241

  Whitaker, Noel J ^a   Glenn, Wendy K ^a   Sahrudin, Arisha ^a   Orde, Matthew M ^b   Delprado, Warick ^c   Lawson, James S ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Douglass Hanly Moir Pathology   (Australia)

Author keywords

Epstein Barr virus; human papillomavirus; koilocytes; prostate cancer

Indexed keywords

ARTICLE; CANCER TISSUE; CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE SEQUENCE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IN SITU POLYMERASE CHAIN REACTION; LIQUID POLYMERASE CHAIN REACTION; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; SEQUENCE ANALYSIS; VIRUS GENE;

BASE SEQUENCE; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMAN PAPILLOMAVIRUS 18; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRUS INFECTIONS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84872803019     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22562     Document Type: Article

References (19)

1. Hagensee ME, Herrel N, D'Angelo A, Sutton K, Clark R, Cameron JE,. Epstein Barr virus interacts with human papilloma virus to decrease apoptosis in vitro and increase cervical dysplasia in vivo. International Centre Genetic Engineering Biotechnology DNA Tumour virus Meeting proceedings. Trieste; 2011. Email for Jennifer Cameron: jcame2@lsuhsc.edu.
2. Lin Y, Mao Q, Zheng X, Yang K, Chen H, Zhou C, Xie L,. Human papillomavirus 16 or 18 infection and prostate cancer risk: A meta-analysis. Ir J Med Sci 2011; 180: 497-503.
3. Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E, Gould VE,. Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res 2002; 62: 4876-4878.
4. Bergh J, Marklund I, Gustavsson C, Wiklund F, Grönberg H, Allard A, Alexeyev O, Elgh F,. No link between viral findings in the prostate and subsequent cancer development. Br J Cancer 2007; 96: 137-139.
5. Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, Isaacs WB,. A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 2008; 68: 306-320.
6. Teo IA, Shaunak S,. Polymerase chain reaction in situ: An appraisal of an emerging technique. Histochemical J 1995; 27: 647-659.
7. Dawkins HJ, Robbins PD, Sarna M, Carrello S, Harvey JM, Sterrett GF,. c-erbB-2 amplification and overexpression in breast cancer: Evaluation and comparison of Southern blot, slot blot, ELISA and immunohistochemistry. Pathology 1993; 25: 124-132.
8. Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES,. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 2006; 39: 727-731.
9. Cinque P, Brytting M, Vago L, Castagna A, Parravicini C, Zanchetta N, D'Arminio Monforte A, Wahren B, Lazzarin A, Linde A,. Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet 1993; 342: 398-401.
10. Reid R, Stanhope CR, Herschman BR, Booth E, Phibbs GD, Smith JP,. Genital warts and cervical cancer. I. Evidence of an association between subclinical papillomavirus infection and cervical malignancy. Cancer 1982; 50: 377-387.
11. Krawczyk E, Suprynowicz FA, Liu X, Dai Y, Hartmann DP, Hanover J, Schlegel R,. Koilocytosis: A cooperative interaction between the human papillomavirus E5 and E6 oncoproteins. Am J Pathol 2008; 173: 682-688.
12. Chen AC, Waterboer T, Keleher A, Morrison B, Jindal S, McMillan D, Nicol D, Gardiner RA, McMillan NA, Antonsson A,. Human papillomavirus in benign prostatic hyperplasia and prostatic adenocarcinoma patients. Pathol Oncol Res 2011; 17: 613-617.
13. Heng B, Glenn WK, Ye Y, Tran D, Delprado W, Lutze-Mann L, Whitaker NJ, Lawson JS,. Human papilloma virus is associated with breast cancer. Br J Cancer 2009; 101: 1345-1350.
14. Antonsson A, Spurr TP, Chen AC, Francis GD, McMillan NA, Saunders NA, Law M, Bennett IC,. High prevalence of human papillomaviruses in fresh frozen breast cancer samples. J Med Virol 2011; 83: 2157-2163.
15. Garland SM, Brotherton JM, Condon JR, McIntyre PB, Stevens MP, Smith DW, Tabrizi SN,. WHINURS study group. Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program. BMC Med 2011; 9: 104.
16. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM,. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: A meta-analysis update. Int J Cancer 2007; 121: 621-631.
17. Lawson JS, Glenn WK, Heng B, Ye Y, Tran B, Lutze-Mann L, Whitaker NJ,. Koilocytes indicate a role for human papilloma virus in breast cancer. Br J Cancer 2009; 101: 1351-1356.
18. Ziol M, Di Tomaso C, Biaggi A, Tepper M, Piquet P, Carbillon L, Uzan M, Guettier C,. Virological and biological characteristics of cervical intraepithelial neoplasia grade I with marked koilocytotic atypia. Hum Pathol 1998; 29: 1068-1073.
19. Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP,. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate 2002; 53: 263-276.